de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons50403

Lange,  B.
Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

Locator
There are no locators available
Fulltext (public)

Leifer.pdf
(Publisher version), 2MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Leifer, I., Blome, S., Blohm, U., Konig, P., Kuster, H., Lange, B., et al. (2012). Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture. Veterinary Research, 43(1): 33. doi:10.1186/1297-9716-43-33.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-F060-4
Abstract
ABSTRACT: Classical swine fever virus (CSFV) C-strain "Riems" escape variants generated under selective antibody pressure with monoclonal antibodies and a peptide-specific antiserum in cell culture were investigated. Candidates with up to three amino acid exchanges in the immunodominant and highly conserved linear TAV-epitope of the E2-glycoprotein, and additional mutations in the envelope proteins ERNS and E1, were characterized both in vitro and in vivo.It was further demonstrated, that intramuscular immunization of weaner pigs with variants selected after a series of passages elicited full protection against lethal CSFV challenge infection. These novel CSFV C-strain variants with exchanges in the TAV-epitope present potential marker vaccine candidates. The DIVA (differentiating infected from vaccinated animals) principle was tested for those variants using commercially available E2 antibody detection ELISA. Moreover, direct virus differentiation is possible using a real-time RT-PCR system specific for the new C-strain virus escape variants or using differential immunofluorescence staining.